Company Overview

Update
Founded:
2005
Founders:
George Colberg
Headquarters:
San Diego, CA
Funding:
$20k
Categories:
Biotechnology
Description:
Kalos Therapeutics develops atrial natriuretic peptides for the treatment of cancer.

Detailed Description

Update

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer. Kalos is aggressively targeting diseases caused by an abnormally high growth rate of cells (hyperproliferation). Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.

Current Team (2)

Update

Funding Rounds (1) - $20k

Update

Offices/Locations (1)

Update
  • Office

    4370 La Jolla Village

    Ste 400

    San Diego, CA 92122

    USA

News (1)

Update

Images (1)

Update
  • Te7gr598qiblbomdceur